WOONSOCKET, R.I.--(BUSINESS WIRE)--Aug 13, 2019--

Abacus Health Products, Inc. (CSE: ABCS, OTCQX: ABAHF) (“Abacus” or the “Company”) will release its 2019 second quarter financial results on Thursday, August 29, 2019, after market close. Management will host a conference call the following day, Friday, August 30, 2019, at 10:00 AM Eastern Time to review the financial results.

Conference Call & Live Audio Webcast Details:

All interested parties can join the conference call by dialing 1.877.800.8397 or 1.615.622.8055, conference ID: 6949749.

A live audio webcast of the conference call will also be available at: https://engage.vevent.com/rt/abacushealthproductsinc/index.jsp?seid=11.

Please dial-in or connect at least 15 minutes prior to the conference call to ensure a secure line and adequate time for any software download that may be required to join the webcast.

Archived Replay:

For those parties unavailable to attend, the conference call will be archived for replay until September 29, 2019. To access the archived conference call, please dial 1.855.859.2056 or 1.404.537.3406 and enter the conference ID 6949749. An archived replay of the webcast will be available for 30 days by clicking the link above.

About Abacus Health Products, Inc.

Abacus is a company engaged in the development and commercialization of over-the-counter (OTC) registered topical medications with active pharmaceutical ingredients and which contain organic and natural ingredients, including a cannabinoid-rich hemp extract containing CBD from Cannabis sativa L plant. Abacus’ products are aimed at the rapidly growing markets for topical pain relief and therapeutic skincare and are based on proprietary patent-pending technologies developed by Abacus. Abacus’ formulations combine advanced science with organic and natural ingredients to provide safe relief. Abacus currently offers two lines of products: (i) CBD CLINIC™, marketed to the professional practitioner market, and (ii) CBDMEDIC™, marketed to the consumer market. Abacus’ products are offered across the United States and are produced by a contract manufacturer in a cGMP compliant and audited manufacturing facility.

To learn more about Abacus, visit www.abacushp.com.

CONTACT: Hank Hague, Chief Financial Officer

Email:investorrelations@abacushp.com

Or

Bill Mitoulas, Investor Relations

Email:bill@abacushp.com

Office: 1.416.479.9547

KEYWORD: UNITED STATES NORTH AMERICA RHODE ISLAND

INDUSTRY KEYWORD: ALTERNATIVE MEDICINE PHARMACEUTICAL HEALTH

SOURCE: Abacus Health Products, Inc.

Copyright Business Wire 2019.

PUB: 08/13/2019 09:04 AM/DISC: 08/13/2019 09:04 AM

Copyright Business Wire 2019.

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.

PLEASE BE ADVISED: Soon we will no longer integrate with Facebook for story comments. The commenting option is not going away, however, readers will need to register for a FREE site account to continue sharing their thoughts and feedback on stories. If you already have an account (i.e. current subscribers, posting in obituary guestbooks, for submitting community events), you may use that login, otherwise, you will be prompted to create a new account.

Load comments